ACTACEL HYBRID
ACTACEL HYBRID
Discontinued
DIN Number
02238684
Drug Class
Human
Market Date
N/A
Company
HC
Sanofi Pasteur Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02238684
AIG Number0834460002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07AG52 HEMOPHILUS INFLUENZAE B, COMBINATIONS WITH PERTUSSIS AND TOXOIDS
Product Specifications
Dosage FormLiquid
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (8)
DIPHTHERIA TOXOIDActive
Strength: 15 LF / 0.5 ML
Monograph: DIPHTHERIA TOXOID
FILAMENTOUS HAEMAGGLUTININActive
Strength: 20 MCG / 0.5 ML
Monograph: FILAMENTOUS HAEMAGGLUTININ
FIMBRIAEActive
Strength: 5 MCG / 0.5 ML
Monograph: FIMBRIAE
PERTACTINActive
Strength: 3 MCG / 0.5 ML
Monograph: PERTACTIN
PERTUSSIS TOXOIDActive
Strength: 20 MCG / 0.5 ML
Monograph: PERTUSSIS TOXOID
POLYRIBOSE RIBITOL PHOSPHATE POLYSACCHARIDE (PRP)Active
Strength: 10 MCG / 0.5 ML
Monograph: POLYRIBOSE RIBITOL PHOSPHATE POLYSACCHARIDE (PRP)
TETANUS PROTEINActive
Strength: 20 MCG / 0.5 ML
Monograph: TETANUS PROTEIN
TETANUS TOXOIDActive
Strength: 5 LF / 0.5 ML
Monograph: TETANUS TOXOID